Browsing by Author Armendariz-Borunda, J

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 63 to 82 of 114 < previous   next >
TitleAuthor(s)???itemlist.dc.contributor.other??????itemlist.dc.contributor.editor???
New Amino Acid Changes in Drug Resistance Sites and HBsAg in Hepatitis B Virus Genotype HFernandez-Galindo, DA; Sanchez-Avila, F; Bobadilla-Morales, L; Gomez-Quiroz, P; Bueno-Topete, M; Armendariz-Borunda, J; Sanchez-Orozco, LV--
New Amino Acid Changes in Drug Resistance Sites and HBsAg in Hepatitis B Virus Genotype HFernandez-Galindo, DA; Sanchez-Avila, F; Bobadilla-Morales, L; Gomez-Quiroz, P; Bueno-Topete, M; Armendariz-Borunda, J; Sanchez-Orozco, LV--
NMDAR-2C and 2D subunits gene expression is induced in brain by neonatal exposure of monosodium L-glutamate to adult ratsBeas-Zárate, Carlos; Flores-Soto, ME; Armendariz-Borunda, J--
NMDAR-2C and 2D subunits gene expression is induced in brain by neonatal exposure of monosodium L-glutamate to adult ratsBeas-Zárate, Carlos; Flores-Soto, ME; Armendariz-Borunda, J--
NRF2 EXPRESSION DOES NOT CORRELATE WITH ANTIOXIDANTS ENZYMES IN EXPERIMENTAL CHOLESTASISBueno-Topete, M; Gonzalez-Cuevas, J; Martinez-Rizo, A; Marquez-Aguirre, AL; Armendariz-Borunda, J--
NRF2 EXPRESSION DOES NOT CORRELATE WITH ANTIOXIDANTS ENZYMES IN EXPERIMENTAL CHOLESTASISBueno-Topete, M; Gonzalez-Cuevas, J; Martinez-Rizo, A; Marquez-Aguirre, AL; Armendariz-Borunda, J--
Overexpression of dominant-negative receptor type-II to TGF-beta inhibits collagen type I by a decrease in Smad-2 and 3 activation.Armendariz-Borunda, J; Hernandez-Canaveral, I; Delgado-jara, V; Gonzalez-Cuevas, J--
Overexpression of dominant-negative receptor type-II to TGF-beta inhibits collagen type I by a decrease in Smad-2 and 3 activation.Armendariz-Borunda, J; Hernandez-Canaveral, I; Delgado-jara, V; Gonzalez-Cuevas, J--
Pirfenidone improves NASH features induced by high fat/carbohydrate diet in miceMacias-Barragan, J; Vera-Cruz, J; Garcia-Banuelos, J; Lopez-de la Mora, DA; Sanchez-Roque, C; Rombouts, K; Marra, F; Pinzani, M; Armendariz-Borunda, J--
Pirfenidone improves NASH features induced by high fat/carbohydrate diet in miceMacias-Barragan, J; Vera-Cruz, J; Garcia-Banuelos, J; Lopez-de la Mora, DA; Sanchez-Roque, C; Rombouts, K; Marra, F; Pinzani, M; Armendariz-Borunda, J--
PIRFENIDONE LIMITS TH2 FIBROGENIC RESPONSE IN EXPERIMENTAL LIVER FIBROSISNovarro-Partida, J; Marquez-Aguirre, A; Martinez-Rizo, A; Gonzalez-Cuevas, J; Golvez-Gostelum, FJ; Bueno-Topete, M; Armendariz-Borunda, J--
PIRFENIDONE LIMITS TH2 FIBROGENIC RESPONSE IN EXPERIMENTAL LIVER FIBROSISNovarro-Partida, J; Marquez-Aguirre, A; Martinez-Rizo, A; Gonzalez-Cuevas, J; Golvez-Gostelum, FJ; Bueno-Topete, M; Armendariz-Borunda, J--
PIRFENIDONE LIMITS TH2 FIBROGENIC RESPONSE IN EXPERIMENTAL LIVER FIBROSIS VIA P38 MAPK INHIBITIONNavarro-Partida, J; Marquez-Aguirre, AL; Galvez-Gastelum, J; Bueno-Topete, MR; Gonzalez-Cuevas, J; Armendariz-Borunda, J--
PIRFENIDONE LIMITS TH2 FIBROGENIC RESPONSE IN EXPERIMENTAL LIVER FIBROSIS VIA P38 MAPK INHIBITIONNavarro-Partida, J; Marquez-Aguirre, AL; Galvez-Gastelum, J; Bueno-Topete, MR; Gonzalez-Cuevas, J; Armendariz-Borunda, J--
PIRFENIDONE MAINTAINS NUCLEAR NRF2 ACTIVATION AND REDUCES PROINFLAMMATORY AND FIBROGENIC EFFECTS INDUCED BY OXIDATIVE STRESS IN HUMAN HEPATIC STELLATE CELLS (HSC)Macias, J; Caligiuri, A; Novo, E; Parola, M; Armendariz-Borunda, J; Pinzani, M--
PIRFENIDONE MAINTAINS NUCLEAR NRF2 ACTIVATION AND REDUCES PROINFLAMMATORY AND FIBROGENIC EFFECTS INDUCED BY OXIDATIVE STRESS IN HUMAN HEPATIC STELLATE CELLS (HSC)Macias, J; Caligiuri, A; Novo, E; Parola, M; Armendariz-Borunda, J; Pinzani, M--
PIRFENIDONE REDUCES FIBROGENIC AND INFLAMMATORY EFFECTS INDUCED BY OXIDATIVE STRESS THROUGH NRF2 ACTIVATION IN HUMAN HEPATIC STELLATE CELLSMacias, J; Caligiuri, A; Novo, E; Parola, M; Pinzani, M; Armendariz-Borunda, J--
PIRFENIDONE REDUCES FIBROGENIC AND INFLAMMATORY EFFECTS INDUCED BY OXIDATIVE STRESS THROUGH NRF2 ACTIVATION IN HUMAN HEPATIC STELLATE CELLSMacias, J; Caligiuri, A; Novo, E; Parola, M; Pinzani, M; Armendariz-Borunda, J--
PIRFENIDONE RESTRICTS T HELPER TYPE 2 DIFFERENTIATION IN VITRO AND LIMITS T HELPER TYPE 2 RESPONSE IN EXPERIMENTAL LIVER FIBROSISNavarro-Partida, J; Martinez-Rizo, A; Gonzalez-Cuevas, J; Arrevillaga-Boni, G; Ortiz-Navarrete, V; Armendariz-Borunda, J--
PIRFENIDONE RESTRICTS T HELPER TYPE 2 DIFFERENTIATION IN VITRO AND LIMITS T HELPER TYPE 2 RESPONSE IN EXPERIMENTAL LIVER FIBROSISNavarro-Partida, J; Martinez-Rizo, A; Gonzalez-Cuevas, J; Arrevillaga-Boni, G; Ortiz-Navarrete, V; Armendariz-Borunda, J--